GSGennadiy V. Selitskiy

Gennadiy V. Selitskiy

*This is an algorithmically generated author record based on publicly available information.

Gennadiy V. Selitskiy has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Astrocytes as a key structural and functional component in the development of mixed dementia

    by G.V. Selitsky, N.D. Sorokina, P.R. Kamchatnov

    Mixed dementia, characterized by a combination of Alzheimer’s disease and cerebrovascular disease (CVD), is prevalent among the elderly population. Accumulated evidence suggests that CVD plays an active role in the neurodegenerative process, enhancing the amyloid and tau pathways and contributing to the progressive disintegration of the brain’s functional and structural networks. This review presents data indicating that astrocytes serve as a critical integrative component, linking the pathologies associated with beta-amyloid and tau protein, dysfunction of the neurovascular unit, blood-brain barrier disorders, and alterations in the glymphatic system in patients with mixed dementia. We discuss the homeostatic roles of astrocytes along with their reactive transformations, characterized by enhanced Ca2+ signaling, metabolic interactions, polarization of aquaporin-4 (AQP4), and various inflammatory phenotypes. Astrocytes emerge as key modulators of systemic brain activity organization and as a central link uniting the pathological processes in mixed dementia. Targeting astrocyte-mediated mechanisms may pave the way for novel therapeutic approaches to address beta-amyloid and tau-proteinopathies.

  • Factors and features of the development of epilepsy in patients with multiple sclerosis

    by N.D. Sorokina, S.S. Pertsov, A.S. Zherdeva, G.V. Selitsky

    The review of Russian and foreign literature analyzes the factors and features of the development of epilepsy in patients with multiple sclerosis (MS). The following are considered as causes of epileptic seizures: acute focal lesions of brain tissue with edema and irritation of the cerebral cortex; the systemic effect of neuroinflammation with impaired ion, electrolyte, and neurotransmitter metabolism; the effect of cytokines; secondary neurodegenerative changes with impaired metabolism of neurotransmitters in long-term MS; comorbidities; the effect of disease-modifying drugs on the occurrence of epileptic seizures, an independent combination of epilepsy and MS. MRI is the gold standard for diagnosing MS; however, it does not detect axon and dendritic damage, so new imaging techniques need to be studied. Neuroplastic changes in epilepsy and MS can be both adaptive and maladaptive, which requires the search for therapeutic interventions that enhance the former and hinder the latter, considering the mechanisms of neuroplasticity in both epilepsy and MS.

  • MR imaging of cytotoxic lesion of the corpus callosum during pneumonia

    by A.S. Zherdeva, N.D. Sorokina, G.V. Selitsky

    A cytotoxic lesion of the corpus callosum is a nonspecific secondary change in the corpus callosum that occurs as a result of various triggers and is detected using MRI. A clinical case of a cytotoxic lesion of the corpus callosum, detected using MRI of the brain with standard modes, is presented, which showed the characteristic changes in the corpus callosum in a patient with pneumonia. A follow-up MRI in 3.5 months, with complete recovery, showed no previously visualized changes in the corpus callosum, providing neuroimaging confirmation of the suspected lesion. MRI can be considered a highly informative method used to diagnose cytotoxic lesions of the corpus callosum, as well as a method of accurate topical diagnosis, allowing for clarification of the localization and extension of the lesion and differentiation from diseases that have similar MR signs.

  • The role of neuroinflammation in the development of seizure activity and autonomic disorders in patients with epilepsy

    by G.V. Selitsky, N.D. Sorokina, P.R. Kamchatnov, S.S. Pertsov

    The literature review provides data on the role of neuroinflammation, including microglial and astrocyte dysfunction, in the development of increased neuronal excitability and excitotoxicity, which can lead to increased seizure activity. The ability of reactive astrocytes to uptake glutamate through specific transporters is reduced, leading to increased cell excitability, excitotoxicity, and, consequently, the occurrence of epileptogenic activity. In general, neuroinflammation is associated with the activation of neuroplasticity, which can be of a maladaptive (aberrant) nature. The activation responses of the sympathetic part of the autonomic nervous system are also closely related to the inflammation, as evidenced by dysregulation of heart rate variability (HRV). The decrease in HRV is closely related to earlier infections, as well as an increase in C-reactive protein and interleukin-6 blood levels. The interrelated processes of neuroinflammation, autonomic dysregulation, and aberrant neuroplasticity are important elements of epilepsy development, which should be considered when choosing the optimal therapy.


  • Physiological aspects of non-pharmacological treatment of musculoskeletal pain syndrome

    by N.D. Sorokina, S.S. Pertsov, G.V. Selitsky, M.V. Korpan, L.A. Savin

    Musculoskeletal pain (MSP) is common and accounts for about a third of all acute and chronic pain syndromes. MSP is a collective term for various diseases. It is a significant burden for patients, society and healthcare. Patients with MSP need for a multimodal therapeutic approach, and correct assessment of clinical status from the perspective of psychophysiological model will be important for determining and influencing the pathogenetic mechanisms of disease. The review is devoted to non-drug treatment of MSP. The authors analyze neuroimaging correlates of analgesia process involving gray matter near cerebral aqueduct and ventral medial prefrontal cortex in patients with MSP. Various pain syndromes and types of nonpharmacological (hardware and psychophysiological) management are considered (therapy with biofeedback based on EMG or cerebral alpha-rhythm, neuromodulation using transcranial magnetic stimulation or transcranial direct current stimulation, virtual and additional reality technologies, stable platforms with biofeedback).


  • Impact of COVID-19 on some neurological and psychological features in epilepsy

    by N.D. Sorokina, S.S. Pertsov, G.V. Selitsky, A.S. Zherdeva, A.V. Tsagashek

    The new coronavirus infection spread around the world in a very short time and turned into a pandemic with a wave-like flow for more than two years. COVID-19infection affects selectively various organs and systems, including the nervous system; neurological manifestations have been reported, including anosmia, encephalopathy, stroke, epileptogenic disorders, which necessitates studies of the course of brain diseases, among which epilepsy occupies a significant place.


  • Clinical and neurophysiological parameters in patients with epilepsy in the long-term period after COVID-19

    by G.V. Selitskiy, N.D. Sorokina, S.S. Pertsov, A.S. Zherdeva, A.V. Tsagashek

    ЦЕЛЬ ИССЛЕДОВАНИЯ Клинико-психофизиологическая оценка динамики состояния пациентов с эпилепсией через 4—6 мес после перенесенной новой коронавирусной инфекции. МАТЕРИАЛ И МЕТОДЫ Проведено открытое контролируемое проспективное сравнительное амбулаторное клинико-физиологическое исследование пациентов с диагнозом «эпилепсия» после перенесенного COVID-19 с апреля по сентябрь 2021 г. (через 4—6 мес после заболевания) средней степени тяжести (n=16), пациентов с диагнозом «эпилепсия», не болевших COVID-19 (n=17), контрольной группы (n=11) после подтвержденного COVID-19 (через 4—6 мес). Все больные находились в возрастном диапазоне от 23 до 50 лет. Клинико-неврологическое и соматическое обследование включало сбор анамнеза, неврологическое обследование, анкетирование, электрокардиографию, электроэнцефалографию (ЭЭГ), клинико-психометрические тесты оценки депрессии и тревоги, анализ вариабельности сердечного ритма. РЕЗУЛЬТАТЫ Выявлено увеличение представленности эпилептиформной активности как в фоновой ЭЭГ, так и более выраженной — при провоцирующих пробах по сравнению с фоновой регистрацией у 26,5% пациентов, которые перенесли COVID-19 по сравнению с группой пациентов с эпилепсией, не перенесших COVID-19. Выявление редких эпилептических приступов в 18,8% случаев в группе больных эпилепсией, перенесших COVID-19, свидетельствует о повышении эпилептогенеза и снижении терапевтического контроля над приступами. При этом в данной группе у 87,5% пациентов выявлено статистически значимое увеличение влияния симпатического отдела нервной системы на регуляцию сердечного ритма и увеличение выраженности тревоги и депрессии. ЗАКЛЮЧЕНИЕ Полученные результаты могут дополнить оценку психоневрологического статуса пациентов с эпилепсией после перенесенного COVID-19, что дает предпосылки к разработке оптимальных направлений для поддержания медикаментозной ремиссии эпилепсии и снижения риска возможного прогрессирования заболевания.


  • Open Access

    Neurophysiological features in patients with migraine at risk for epilepsy

    by N. D. Sorokina, A. V. Tsagashek, S. S. Pertsov, G. V. Selitsky, A. S. Zherdeva

    Objective: to study the electrophysiological parameters of brain bioelectric activity and features of the autonomous nervous system assessing heart rate variability, sympathetic skin response, clinical and physiological tests depending on the lateralization of migraine pain syndrome in the right or left brain hemisphere in patients with epileptic electroencephalogram (EEG) signs and migraine.Material and methods. Thirty six patients with aura-free episodic migraine at risk of developing epilepsy and 9 age-matched healthy subjects were examined. All participants underwent EEG, clinical and physiological tests, assessment of heart rate variability and sympathetic skin response.Results. Patients with right-hemisphere migraine headache had signs of activated sympathetic nervous system at baseline level and during exercise, lower baseline EEG epileptiform activity and in provocative tests. In contrast to the subjects of this group, patients of other group featured with a more stable migraine pain syndrome in the left hemisphere tended to dominate with functional activity of the parasympathetic system such as increased trophotropic support during exercise, as well as greater magnitude of baseline epileptiform bioelectric activity and during load tests.Conclusion. Values of heart rate variability in combination with objective results of clinical and physiological assessment of the autonomous nervous system and electrophysiological parameters of brain bioelectric activity are reliable prognostic indicators for varying functional conditions in patients with episodic migraine.


  • Open Access

    Physiological correlates of neuro- and magnetic stimulation in therapy of epilepsy

    by Nataliya D. Sorokina, Sergey S. Pertsov, Gennadiy V. Selitskiy, Перцов Сергей Сергеевич

    In the literature survey, non-pharmaceutical methods of therapy of epilepsy are considered including electrostimulation of vagus nerve, exposure to magnetic field and transcranial magnetic stimulation (TMS). Correlates of the effectiveness of electro- and magnetic stimulation are electrophysiological parameters, clinical data and influence on the mental and cognitive functions. Use of repetitive transcranial magnetic stimulation in addition to antiepileptic drugs has a certain ground. According to modern understanding and the results of experimental studies, the mechanism of modulator inhibitory alterations is associated with a potential of TMS to cause long-term synaptic depression or long-term potentiation. These long-lasting phenomena probably underlie anticonvulsant effects of low frequency magnetic stimulation. Inclusion of physiologists and neurophysiologists into the research will permit to solve such an important problem as a study of physiological mechanisms of the effectiveness of non-pharmacological electro- and magnetic action in epilepsy.